Proximal Humerus Fixation System

K242436 · Skeletal Dynamics, Inc. · HRS · Nov 14, 2024 · Orthopedic

Device Facts

Record IDK242436
Device NameProximal Humerus Fixation System
ApplicantSkeletal Dynamics, Inc.
Product CodeHRS · Orthopedic
Decision DateNov 14, 2024
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 888.3030
Device ClassClass 2
AttributesTherapeutic

Intended Use

The Proximal Humerus Fixtion System is indicated for fractures and fracture dislocations, osteotomies, and non-unions of the proximal humerus.

Device Story

Proximal Humerus Fixation System consists of titanium alloy bone plates, titanium screws, and cobalt chrome screws/pegs; used for stabilization/repair of proximal humerus fractures, dislocations, osteotomies, and non-unions. Implants provided non-sterile for facility-based sterilization. System includes accessory plates for greater tuberosity fixation. Operated by orthopedic surgeons in clinical/surgical settings. Provides mechanical fixation to bone segments to facilitate healing; performance verified via mechanical testing against predicate standards.

Clinical Evidence

Bench testing only. Mechanical testing performed per ASTM F382-17 (static/dynamic plate testing) and ASTM F543-23 (driving torque, torsional yield strength, axial pullout for screws) demonstrated equivalence to predicate devices.

Technological Characteristics

Materials: Titanium Alloy (Ti-6Al-4V ELI), Cobalt Chrome (CoCr). Components: Bone plates, screws, pegs. Standards: ASTM F382-17 (plates), ASTM F543-23 (screws). Sterilization: Non-sterile, facility-sterilized. Connectivity: None.

Indications for Use

Indicated for patients requiring stabilization of fractures, fracture dislocations, osteotomies, and non-unions of the proximal humerus.

Regulatory Classification

Identification

Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

Reference Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue. November 14, 2024 Skeletal Dynamics, Inc. Alexandra Rodriguez Rojas Regulatory Affairs Manager 7300 North Kendall Drive Suite 800 Miami, Florida 33156 Re: K242436 Trade/Device Name: Proximal Humerus Fixation System Regulation Number: 21 CFR 888.3030 Regulation Name: Single/Multiple Component Metallic Bone Fixation Appliances And Accessories Regulatory Class: Class II Product Code: HRS, HWC Dated: August 16, 2024 Received: August 16, 2024 Dear Alexandra Rodriguez Rojas: We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download). Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181). Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050. All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-device-advicecomprehensive-regulatory-assistance/unique-device-identification-system-udi-system. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatory {2}------------------------------------------------ assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, # CHRISTOPHER FERREIRA -S Christopher Ferreira, M.S. Assistant Director DHT6C: Division of Restorative, Repair, and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ #### DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration ## Indications for Use Form Approved: OMB No. 0910-0120 Expiration Date: 07/31/2026 See PRA Statement below. Submission Number (if known) K242436 Device Name Proximal Humerus Fixation System Indications for Use (Describe) The Proximal Humerus Fixtion System is indicated for fractures and fracture dislocations, osteotomies, and non-unions of the proximal humerus. Type of Use (Select one or both, as applicable) > Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) ### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. ### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {4}------------------------------------------------ Image /page/4/Picture/0 description: The image contains the logo for Skeletal Dynamics. The logo consists of a green and blue abstract symbol on the left, followed by the words "skeletal dynamics" in a sans-serif font. The word "skeletal" is in a darker blue, while "dynamics" is in a lighter blue. A registered trademark symbol is present to the right of the word "dynamics". ### K242436 510(k) SUMMARY Skeletal Dynamic's Proximal Humerus Fixation System ### Submitter Skeletal Dynamics, Inc. 7300 N. Kendall Drive, Suite 800 Miami, FL 33156 Phone : 305-596-7585 E-mail : arodriguez(@skeletaldynamics.com Contact Person: Alexandra Rodriguez Rojas Date Prepared: November 08th, 2024 ### Name and Classification Trade Name: Proximal Humerus Fixation System Common Name: Plate, Fixation, Bone (Primary), Screw, Fixation, Bone. Classification Name: Single/multiple component metallic bone fixation appliances and Accessories (Primary), Smooth or threaded metallic bone fixation fastener Classification Number: 21 CFR §888.3030 (Primary), 21 CFR §888.3040 Regulatory Class: Class II Product Code: HRS (Primary), HWC ### Primary Predicate Device - Biomet A.L.P.S Proximal Humerus Fixation System (ALPS PHP) (K143697) . ### Additional Predicate - 4.0 mm screws of the Stryker AxSOS 3 Ti System (K181091) . ### Reference Devices - Distal Humerus Plating System (K213895) ● ### Device Description The Skeletal Dynamics Proximal Humerus Fixation System is a set of medical-grade Titanium Alloy (Ti-6Al-4V ELI) bone plates and Titanium and Cobalt Chrome (CoCr) screws and pegs designed for the stabilization and repair of fractures and fracture dislocations, osteotomies, and non-unions of the proximal humerus in conjunction with general and specialized instrumentation. The implants and instruments are provided non-sterile and shall be sterilized at the health care facility. ### Indications for Use The Proximal Humerus Fixation System is indicated for fractures and fracture dislocations, osteotomies, and non-unions of the proximal humerus. ### Substantial Equivalence The Proximal Humerus Fixation System is substantially equivalent to the primary predicate A.L.P.S Proximal Humerus Fixation System (ALPS PHP), formerly referred to as Biomet Proximal Humerus Fixation System (K143697) and to the 4.0 mm screws of the additional {5}------------------------------------------------ Image /page/5/Picture/0 description: The image contains the logo for Skeletal Dynamics. The logo consists of a stylized green and blue symbol on the left, followed by the words "skeletal dynamics" in a dark blue sans-serif font. The word "skeletal" is on top of the word "dynamics", and there is a registered trademark symbol next to the word "dynamics". predicate Stryker AxSOS 3 Ti System (K181091). Minor differences in the technological characteristics and indications for use do not present any concerns related to safety or effectiveness of the device. ### Comparison of Technological Characteristics with the Predicate Device The subiect Proximal Humerus Fixation System is substantially equivalent to the primary predicate Biomet A.L.P.S. Proximal Humerus Fixation System and to the 4.0 screws of the additional predicate Stryker AxSOS 3 Ti System (K181091). Both predicate systems consist of the same types of components (bone plates and bone screws) as the subject device. Both predicate devices also provide suture holes within the head of the plates, like the subject proximal humerus plates. Both predicate devices offer 4.0 mm Cancellous Locking Screws. The primary predicate includes at least one curved plate configuration like the subject device and bending features on the plate. Finally, the primary predicate and the subject device offer additional options for the fixation of the greater tuberosity. The subject device offers accessory plates for this purpose, while the predicate device offers suture holes in their plate configurations. The primary difference between the subject device and its predicate devices is the geometry of the plates and the screw designs. Additionally, the subject system includes accessory plates that aid in the fixation of the greater tuberosity when needed. The predicate device includes suture holes in their plates for the same purpose of fixation of the greater tuberosity when needed. These differences in technology do not raise any new questions of safety or effectiveness due to the subject proximal humerus plates and screws performance testing results meeting the FDA guidance's that also cover the predicate devices. ### Performance Testing Engineering analysis and mechanical testing demonstrated that the Skeletal Dynamics Proximal Humerus Fixation System is equivalent to predicate devices currently marketed. Static and Dynamic testing per ASTM F382-17 established equivalency for the plates. Driving Torque, Torsional Yield Strength, and Axial Pullout testing per ASTM 543-23 established equivalency for the screws. Therefore, the subject device is as safe and effective as the legally marketed predicate device. ### Conclusions The Skeletal Dynamics' Proximal Humerus Fixation System is substantially equivalent to the predicate devices identified in this premarket notification.
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%